新型内镜下虚拟色素内镜评分PICaSSO在溃疡性结肠炎中的开发与可靠性
本研究开发并验证了用于溃疡性结肠炎的内镜虚拟色素内镜评分PICaSSO,8名参与者经过培训后评估20个视频片段。PICaSSO的观察者间一致性在测试前后均很好(κ=0.92和0.89),对组织学异常和炎症的评估准确率在57%至83%之间。结论认为PICaSSO可能用于定义黏膜和血管愈合的内镜表现,并反映组织学变化的全谱。
要点
- PICaSSO评分在测试前后观察者间一致性均很好(κ=0.92和0.89)。
- PICaSSO评估组织学异常和炎症的准确率:Harpaz评分57%,Robarts组织学指数72%,ECAP系统83%。
- PICaSSO可能用于定义溃疡性结肠炎黏膜和血管愈合的内镜表现。
核心结论
- PICaSSO评分显示很好的观察者间一致性。
- 新型PICaSSO评分可能用于定义溃疡性结肠炎黏膜和血管愈合的内镜表现,并反映组织学变化的全谱。
研究设计与样本
- 开发与验证研究,8名参与者审阅60分钟培训模块,涵盖3种i-SCAN模式。
- 使用20个视频片段在测试前和测试后评估内镜评分及预测组织学炎症的性能特征。
主要发现
- Mayo内镜评分的观察者间一致性在测试前为κ=0.85(95%CI 0.78-0.90),测试后为κ=0.85(95%CI 0.77-0.90)。
- 溃疡性结肠炎内镜严重程度指数的观察者间一致性在测试前为κ=0.86(95%CI 0.77-0.92),测试后为κ=0.84(95%CI 0.75-0.91)。
- PICaSSO内镜评分的观察者间一致性在测试前为κ=0.92(95%CI 0.87-0.96),测试后为κ=0.89(95%CI 0.84-0.94)。
- PICaSSO评估组织学异常和炎症的准确率:Harpaz评分为57%(95%CI 48%-65%),Robarts组织学指数为72%(95%CI 64%-79%),ECAP系统为83%(95%CI 76%-88%)。
关键数值与推荐
- PICaSSO内镜评分观察者间一致性κ=0.92(95%CI 0.87-0.96)和κ=0.89(95%CI 0.84-0.94)。
- PICaSSO评估组织学异常和炎症准确率:Harpaz评分57%(95%CI 48%-65%),Robarts组织学指数72%(95%CI 64%-79%),ECAP系统83%(95%CI 76%-88%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Endoscopic inflammation and healing are important therapeutic endpoints in ulcerative colitis (UC). We developed and validated a new electronic virtual chromoendoscopy (EVC) score that could reflect the full spectrum of mucosal and vascular changes including mucosal healing in UC. METHODS: Eight participants reviewed a 60-minute training module outlining 3 different i-SCAN modes demonstrating the entire spectrum of inflammatory mucosal and vascular changes in UC. Performance characteristics in endoscopic scoring and predicting the histologic inflammation with EVC (i-SCAN) by using 20 video clips before (pre-test) and after (post-test) were evaluated. Exploratory univariate factor analysis was performed on Paddington International Virtual Chromoendoscopy Score (PICaSSO) covariates for mucosal and vascular score separately. Subsequently, a proportional odds logistic regression model for the prediction of histologic scores was analyzed. RESULTS: The interobserver agreement for Mayo endoscopic score in the pre-test (κ = .85; 95% CI, .78-.90) and the post-test (κ = .85; 95% CI, .77-.90) evaluation were very good. This was also true for the Ulcerative Colitis Endoscopic Index of Severity in the pre-test and post-test score interobserver agreement (κ = .86; 95% CI, .77-.92; and κ = .84; 95% CI, .75-.91, respectively). The interobserver agreement of the PICaSSO endoscopic score was very good in the pre-test and post-test evaluations (κ = .92; 95% CI, .87-.96; and κ = .89; 95% CI, .84-.94, respectively). The accuracy of the overall PICaSSO in assessing histologic abnormalities and inflammation by Harpaz score was 57% (95% CI, 48%-65%), by Robarts Histological Index 72% (95% CI, 64%-79%), and by the extent, chronicity, activity, plus system (full spectrum of histologic changes) 83% (95% CI, 76%-88%). CONCLUSIONS: The EVC score "PICaSSO" showed very good interobserver agreement. The new EVC score may be used to define the endoscopic findings of mucosal and vascular healing in UC and reflected the full spectrum of histologic changes.
引用
- Iacucci M, Daperno M, Lazarev M, et al. Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis. Gastrointest Endosc. 2017. PMID: 28322774. doi:10.1016/j.gie.2017.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。